SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Referral — Ida B. Wells

PatientIda B. Wells
Date of birth1957-07-16
IdentifiersMRN HR-ET022-SYN; SSN (made up) 000-22-5903
Document date2026-01-05
AuthorCordelia Ashworth-Banks, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

New chronic kidney disease, probably G3b A2, of uncertain cause in a 68-year-old Black woman with tiredness, ankle swelling and high blood pressure readings: race-free eGFR 40 by creatinine and 38 with cystatin C, and a urine albumin-to-creatinine ratio of 240 mg/g. Please advise on the cause and further evaluation, APOL1 genetic testing, kidney-protective treatment and its order, the anemia and mineral findings, and how and when to plan for the future. [S]

Urgency: Within two weeks, on the day of her two-week visit, after the repeat urine test and the kidney ultrasound. [S]

Questions for the consultant:

History of Present Illness

Mrs. Wells is a journalist and civic leader, active and independent, who has been tired for some months and notices ankle swelling by evening. She has taken over-the-counter naproxen for knee aching for about a year; it was stopped today. She has no diabetes symptoms, no known kidney disease, and no blood in the urine. She recalls being told by another clinic two years ago that a kidney test was normal and is obtaining that report. Her parents and an infant brother died in an epidemic in her youth; no family kidney history is known. Blood pressure 164/94 (average of two readings), pulse 78, weight 70.4 kg, BMI 28.6; trace ankle swelling. Results today: sodium 139, potassium 4.6, bicarbonate 22 mmol/L; urea nitrogen 28, creatinine 1.42 mg/dL; eGFR 40 (CKD-EPI 2021 creatinine, race-free); cystatin C 1.68 mg/L, eGFR 38 (creatinine and cystatin C); urine albumin-to-creatinine ratio 240 mg/g; fasting glucose 94 mg/dL and A1c 5.6%; hemoglobin 11.2 g/dL, ferritin 168 ng/mL, transferrin saturation 24%; calcium 9.2, phosphate 3.8 mg/dL; intact PTH 84 pg/mL; 25-hydroxyvitamin D 17 ng/mL; LDL 136 mg/dL; TSH 1.9; PHQ-9 4. ECG: sinus rhythm with voltage criteria for left ventricular hypertrophy. Sent today: urinalysis with microscopy, serum protein electrophoresis with free light chains, hepatitis B, hepatitis C and HIV tests. Planned: a home blood pressure monitor for seven days, a repeat urine albumin test and a kidney ultrasound on the morning of your visit. She asks to see every result and how each was calculated [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxenOne or two tablets up to three times a day as neededOral route2026-01-05activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be establishedactiveconfirmed R94.4S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks.
Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirmactiveconfirmed R03.0S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

No historical medical events are recorded.

Family History

RelativeConditionAge at deathEvidence
fatherDied in the yellow fever epidemic when she was 16D (CLM-0002)
motherDied in the yellow fever epidemic when she was 16D (CLM-0002)
brotherAn infant brother died in the same yellow fever epidemicD (CLM-0002)

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-01-05Body height157cmS
2026-01-05Body weight70.4kgS
2026-01-05Body mass index (BMI) [Ratio]28.6kg/m2S
2026-01-05Systolic blood pressure164mm[Hg]S
2026-01-05Diastolic blood pressure94mm[Hg]S
2026-01-05Heart rate78/minS
2026-01-05Respiratory rate16/minS
2026-01-05Body temperature36.6CelS
2026-01-05Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-05Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-01-05Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-01-05Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/LKeep at 22 or above in kidney diseaseNormalS
2026-01-05Urea nitrogen [Mass/volume] in Serum or Plasma28mg/dL8-23 mg/dLHighS
2026-01-05Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-01-05Creatinine [Mass/volume] in Serum or Plasma1.42mg/dL0.59-1.04 mg/dLHighS
2026-01-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M40mL/min/{1.73_m2}60 or higher without other kidney damage markers; 45 to 59 is G3a, 30 to 44 is G3b, 15 to 29 is G4LowS
2026-01-05Cystatin C [Mass/volume] in Serum or Plasma1.68mg/L0.53-0.95 mg/LHighS
2026-01-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine and Cystatin C-based formula (CKD-EPI 2021)/1.73 sq M38mL/min/{1.73_m2}The confirmatory estimate KDIGO prefers when decisions depend on accuracy; 30 to 44 is G3bLowS
2026-01-05Albumin/Creatinine [Mass Ratio] in Urine240mg/gBelow 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3)HighS
2026-01-05Hemoglobin A1c/Hemoglobin.total in Blood5.6%Below 5.7% is normal; 6.5% or higher is diabetesNormalS
2026-01-05Hemoglobin [Mass/volume] in Blood11.2g/dLAnemia in women is below 12.0 g/dLLowS
2026-01-05Ferritin [Mass/volume] in Serum or Plasma168ng/mL30-300 ng/mLNormalS
2026-01-05Iron saturation [Mass Fraction] in Serum or Plasma24%20-50%NormalS
2026-01-05Calcium [Mass/volume] in Serum or Plasma9.2mg/dL8.6-10.3 mg/dLNormalS
2026-01-05Phosphate [Mass/volume] in Serum or Plasma3.8mg/dL2.5-4.5 mg/dLNormalS
2026-01-05Parathyrin.intact [Mass/volume] in Serum or Plasma84pg/mL15-65 pg/mLHighS
2026-01-0525-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma17ng/mLBelow 20 ng/mL deficient; 20 to 29 insufficientLowS
2026-01-05Cholesterol [Mass/volume] in Serum or Plasma214mg/dL<=199 mg/dLHighS
2026-01-05Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation136mg/dL<=99 mg/dLHighS
2026-01-05Cholesterol in HDL [Mass/volume] in Serum or Plasma52mg/dL>=50 mg/dLNormalS
2026-01-05Triglyceride [Mass/volume] in Serum or Plasma128mg/dL<=149 mg/dLNormalS
2026-01-05Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4.5 mIU/LNormalS
2026-01-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S

Assessment

Plan of Treatment